litlas
Log inCreate account

James J. Moon

Active 2000–2025

119
Papers
18,428
Citations
67
h-index
118
i10-index

Citations

Citations per year for James J. Moon1968: 1 citations1993: 1 citations2000: 2 citations2001: 14 citations2002: 15 citations2003: 10 citations2004: 6 citations2005: 14 citations2006: 19 citations2007: 19 citations2008: 41 citations2009: 67 citations2010: 72 citations2011: 83 citations2012: 89 citations2013: 78 citations2014: 100 citations2015: 106 citations2016: 111 citations2017: 148 citations2018: 205 citations2019: 669 citations2020: 1,020 citations2021: 1,272 citations2022: 1,190 citations2023: 1,149 citations2024: 1,564 citations2025: 932 citations2026: 23 citations1969–1992: no citations, so these years are not shown1994–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,482 citing papers, 32.7% of this breakdownUnited States: 2,457 citing papers, 23.1% of this breakdownSouth Korea: 372 citing papers, 3.5% of this breakdownUnited Kingdom: 314 citing papers, 2.9% of this breakdownIndia: 298 citing papers, 2.8% of this breakdownGermany: 294 citing papers, 2.8% of this breakdownCanada: 221 citing papers, 2.1% of this breakdownAustralia: 213 citing papers, 2% of this breakdownFrance: 194 citing papers, 1.8% of this breakdownItaly: 177 citing papers, 1.7% of this breakdownJapan: 169 citing papers, 1.6% of this breakdownSingapore: 167 citing papers, 1.6% of this breakdown
0%32.7%Other 21.4%

Institutions

Fields

  • Immunology and Microbiology23.8%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Medicine21.2%
  • Engineering19.4%
  • Materials Science6.6%
  • Pharmacology, Toxicology and Pharmaceutics2.5%
  • Other3.9%

Topics

  • Nanoplatforms for cancer theranostics8.8%
  • Immunotherapy and Immune Responses8%
  • RNA Interference and Gene Delivery4.7%
  • Nanoparticle-Based Drug Delivery3.6%
  • Cancer Immunotherapy and Biomarkers3%
  • Immune cells in cancer2.8%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy

    Authors: Xiaoqi Sun, Yu Zhang, Jiaqian Li, Kyong Soo Park, Kai Han, Xingwu Zhou, Yao Xu, Jutaek Nam, Jin Xu, Xiaoyue Shi, Lei Wei, Yu L. Lei, James J. Moon - Nature Nanotechnology 2021 cited by 752

  2. Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis

    Authors: Yonghyun Lee, Kohei Sugihara, Merritt Gillilland, Sangyong Jon, Nobuhiko Kamada, James J. Moon - Nature Materials 2019 cited by 700

  3. Cancer nanomedicine for combination cancer immunotherapy

    Authors: Jutaek Nam, Sejin Son, Kyong Soo Park, Weiping Zou, Lonnie D. Shea, James J. Moon - Nature Reviews Materials 2019 cited by 928

  4. Designer vaccine nanodiscs for personalized cancer immunotherapy

    Authors: Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat, Anna Schwendeman, James J. Moon - Nature Materials 2016 cited by 1,054

  5. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel

    Authors: Kai Han, Jutaek Nam, Jin Xu, Xiaoqi Sun, Xuehui Huang, Olamide Animasahun, Abhinav Achreja, Jin Heon Jeon, Benjamin Pursley, Nobuhiko Kamada, Grace Chen, Deepak Nagrath, James J. Moon - Nature Biomedical Engineering 2021 cited by 262

  6. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis

    Authors: Eduard Ansaldo, Leianna C. Slayden, Krystal L. Ching, Meghan A. Koch, Natalie K. Wolf, Damian R. Plichta, Eric Brown, Daniel B. Graham, Ramnik J. Xavier, James J. Moon, Gregory M. Barton - Science 2019 cited by 568

  7. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer

    Authors: Briana G. Nixon, Fengshen Kuo, Liangliang Ji, Ming Liu, Kristelle J. Capistrano, Mytrang Do, Ruth A. Franklin, Xiaodi Wu, Emily R. Kansler, Raghvendra M. Srivastava, Tanaya A. Purohit, Alejandro Sánchez, Lynda Vuong, Chirag Krishna, Xinxin Wang, Herbert C. Morse, James J. Hsieh, Timothy A. Chan, Kenneth M. Murphy, James J. Moon, A. Ari Hakimi, Ming O. Li - Immunity 2022 cited by 188

  8. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer

    Authors: Jutaek Nam, Sejin Son, Lukasz J. Ochyl, Rui Kuai, Anna Schwendeman, James J. Moon - Nature Communications 2018 cited by 807

  9. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome

    Authors: Yonghyun Lee, Nobuhiko Kamada, James J. Moon - Advanced Drug Delivery Reviews 2021 cited by 148

  10. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

    Authors: Matthias T. Stephan, James J. Moon, Soong Ho Um, Anna Bershteyn, Darrell J. Irvine - Nature Medicine 2010 cited by 738

  11. Strategies for the development of metalloimmunotherapies

    Authors: Xiaoqi Sun, Xingwu Zhou, Xiaoyue Shi, Omar A. Abed, Xinran An, Yu L. Lei, James J. Moon - Nature Biomedical Engineering 2024 cited by 144

  12. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy

    Authors: Marisa Aikins, Cheng Xu, James J. Moon - Accounts of Chemical Research 2020 cited by 229

  13. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock

    Authors: Emeka B. Okeke, Cameron Louttit, Chris Fry, Alireza Hassani Najafabadi, Kai Han, Jean A. Nemzek, James J. Moon - Biomaterials 2020 cited by 187

  14. A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes

    Authors: Tiffany C. Scharschmidt, Kimberly S. Vasquez, Hong-An Truong, Sofia V. Gearty, Mariela Pauli, Audrey Nosbaum, Iris K. Gratz, Michaël Otto, James J. Moon, Jan Liese, Abul K. Abbas, Michael A. Fischbach, Michael D. Rosenblum - Immunity 2015 cited by 558

  15. Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy

    Authors: Yonghyun Lee, Jongyoon Shinn, Cheng Xu, Hannah E. Dobson, Nouri Neamati, James J. Moon - Nature Communications 2023 cited by 84

  16. Engineering patient-specific cancer immunotherapies

    Authors: Lindsay Scheetz, Kyong Soo Park, Qiao Li, Pedro R. Löwenstein, María G. Castro, Anna Schwendeman, James J. Moon - Nature Biomedical Engineering 2019 cited by 205

  17. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy

    Authors: Rui Kuai, Wenmin Yuan, Sejin Son, Jutaek Nam, Yao Xu, Yuchen Fan, Anna Schwendeman, James J. Moon - Science Advances 2018 cited by 348

  18. A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes

    Authors: Djenet Bousbaine, Laura Fisch, Mariya London, Preksha Bhagchandani, Tiago B. R. Castro, Mark Mimee, Scott W. Olesen, Bernardo Sgarbi Reis, David VanInsberghe, Juliana Bortolatto, Mathilde Poyet, Ross W. Cheloha, John Sidney, Jingjing Ling, Aaron Gupta, Timothy K. Lu, Alessandro Sette, Eric J. Alm, James J. Moon, Gabriel D. Victora, Daniel Mucida, Hidde L. Ploegh, Angelina M. Bilate - Science 2022 cited by 100

  19. Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy

    Authors: Jongyoon Shinn, Seojeong Park, Seonju Lee, Nayoon Park, Seojeong Kim, Seohui Hwang, James J. Moon, Youngjoo Kwon, Yonghyun Lee - ACS Nano 2024 cited by 86

  20. High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles

    Authors: Rui Kuai, Dan Li, Y. Eugene Chen, James J. Moon, Anna Schwendeman - ACS Nano 2016 cited by 341

  21. Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells

    Authors: Daniel DiToro, Colleen J. Winstead, Duy Pham, Steven Witte, Rakieb Andargachew, Jeffrey R. Singer, C. Garrett Wilson, Carlene L. Zindl, Rita J. Luther, Daniel J. Silberger, Benjamin T. Weaver, Elizabeth Motunrayo Kolawole, Ryan J. Martinez, Henrietta Turner, Robin D. Hatton, James J. Moon, Sing Sing Way, Brian D. Evavold, Casey T. Weaver - Science 2018 cited by 241

  22. Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice

    Authors: Padma Kadiyala, Stephen V. Carney, Jessica C. Gauss, María Belén Garcia-Fabiani, Santiago Haase, Mahmoud S. Alghamri, Felipe J. Núñez, Yayuan Liu, Minzhi Yu, Ayman Taher, Fernando M. Núñez, Dan Li, Marta Edwards, Celina G. Kleer, Henry D. Appelman, Yilun Sun, Lili Zhao, James J. Moon, Anna Schwendeman, Pedro R. Löwenstein, María G. Castro - Journal of Clinical Investigation 2020 cited by 139

  23. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy

    Authors: Cheng Xu, Jutaek Nam, Hao Hong, Yao Xu, James J. Moon - ACS Nano 2019 cited by 199

  24. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

    Authors: Gaopeng Li, Ilona Kryczek, Jutaek Nam, Xiong Li, Shasha Li, Jing Li, Shuang Wei, Sara Grove, Linda Vatan, Jiajia Zhou, Wan Du, Heng Lin, Ton Wang, Chitra Subramanian, James J. Moon, Marcin Cieślik, Mark S. Cohen, Weiping Zou - Nature Cell Biology 2021 cited by 225